Human centenarian–associated SIRT6 mutants modulate hepatocyte metabolism and collagen deposition in multilineage hepatic 3D spheroids

[1]  Poonam Kalhotra,et al.  Regulation of tumor metabolism by post translational modifications on metabolic enzymes , 2022, Cancer Gene Therapy.

[2]  M. Vinciguerra,et al.  Histone Variant macroH2A1.1 Enhances Nonhomologous End Joining-dependent DNA Double-strand-break Repair and Reprogramming Efficiency of Human iPSCs. , 2022, Stem cells.

[3]  M. Vinciguerra,et al.  ITCH E3 ubiquitin ligase downregulation compromises hepatic degradation of branched-chain amino acids , 2022, Molecular metabolism.

[4]  J. Fallowfield,et al.  In vitro models for non-alcoholic fatty liver disease: Emerging platforms and their applications , 2021, iScience.

[5]  OUP accepted manuscript , 2022, Stem Cells.

[6]  P. Hockings,et al.  Hepatic Unsaturated Fatty Acids Are Linked to Lower Degree of Fibrosis in Non-alcoholic Fatty Liver Disease , 2022, Frontiers in Medicine.

[7]  B. Garcia,et al.  A rare human centenarian variant of SIRT6 enhances genome stability and interaction with Lamin A , 2021, bioRxiv.

[8]  H. Tilg,et al.  Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity , 2021, Nature Metabolism.

[9]  A. Shevchenko,et al.  Nonalcoholic fatty liver disease stratification by liver lipidomics , 2021, Journal of lipid research.

[10]  C. Mantzoros,et al.  Preparing for the NASH Epidemic: A Call to Action. , 2021, Gastroenterology.

[11]  A. Seluanov,et al.  Sirtuin 6: linking longevity with genome and epigenome stability. , 2021, Trends in cell biology.

[12]  C. Mantzoros,et al.  Preparing for the NASH epidemic: A call to action. , 2021, Metabolism: clinical and experimental.

[13]  R. de Cabo,et al.  Restoration of energy homeostasis by SIRT6 extends healthy lifespan , 2021, Nature Communications.

[14]  M. Vinciguerra,et al.  GDF11 rapidly increases lipid accumulation in liver cancer cells through ALK5-dependent signaling. , 2021, Biochimica et biophysica acta. Molecular and cell biology of lipids.

[15]  O. Ayonrinde.  Historical narrative from fatty liver in the nineteenth century to contemporary NAFLD – Reconciling the present with the past , 2021, JHEP reports : innovation in hepatology.

[16]  M. Allison,et al.  The European NAFLD registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease. , 2020, Contemporary clinical trials.

[17]  I. Sakaida,et al.  Metabolic Alterations in Spheroid-Cultured Hepatic Stellate Cells , 2020, International journal of molecular sciences.

[18]  R. Schwabe,et al.  Mechanisms of Fibrosis Development in Nonalcoholic Steatohepatitis , 2020 .

[19]  N. C. Talukdar,et al.  Post-translational Modification Crosstalk and Hotspots in Sirtuin Interactors Implicated in Cardiovascular Diseases , 2020, Frontiers in Genetics.

[20]  R. Schwabe,et al.  SIRT6 Protects Against Liver Fibrosis by Deacetylation and Suppression of SMAD3 in Hepatic Stellate Cells , 2020, Cellular and molecular gastroenterology and hepatology.

[21]  V. Wong,et al.  A new definition for metabolic associated fatty liver disease: an international expert consensus statement. , 2020, Journal of hepatology.

[22]  R. Schwabe,et al.  Mechanisms of Fibrosis Development in NASH. , 2020, Gastroenterology.

[23]  P. Bai,et al.  The role of ADP-ribose metabolism in metabolic regulation, adipose tissue differentiation, and metabolism , 2020, Genes & development.

[24]  Inigo Martincorena,et al.  Somatic mutations and clonal dynamics in healthy and cirrhotic human liver , 2019, Nature.

[25]  S. Dakshinamurti,et al.  Effects of Post-translational Modifications on Membrane Localization and Signaling of Prostanoid GPCR–G Protein Complexes and the Role of Hypoxia , 2019, The Journal of Membrane Biology.

[26]  Byung-Hyun Park,et al.  Deacetylation of XBP1s by sirtuin 6 confers resistance to ER stress-induced hepatic steatosis , 2019, Experimental & Molecular Medicine.

[27]  S. Signorelli,et al.  Inhibition of Heme Oxygenase Antioxidant Activity Exacerbates Hepatic Steatosis and Fibrosis In Vitro , 2019, Antioxidants.

[28]  Eun-Hee Kim,et al.  Therapeutic Effects of Amino Acids in Liver Diseases: Current Studies and Future Perspectives , 2019, Journal of cancer prevention.

[29]  A. Sanyal.  Past, present and future perspectives in nonalcoholic fatty liver disease , 2019, Nature Reviews Gastroenterology & Hepatology.

[30]  Z. Younossi,et al.  Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States , 2019, BMC Gastroenterology.

[31]  Zhengdong D. Zhang,et al.  SIRT6 Is Responsible for More Efficient DNA Double-Strand Break Repair in Long-Lived Species , 2019, Cell.

[32]  S. Prill,et al.  Human Multilineage 3D Spheroids as a Model of Liver Steatosis and Fibrosis , 2019, International journal of molecular sciences.

[33]  Jinhang Zhang,et al.  Hepatocyte-specific Sirt6 deficiency impairs ketogenesis , 2018, The Journal of Biological Chemistry.

[34]  M. Manns,et al.  Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030. , 2018, Journal of hepatology.

[35]  M. Vinciguerra,et al.  Histone variant macroH2A1 rewires carbohydrate and lipid metabolism of hepatocellular carcinoma cells towards cancer stem cells , 2018, Epigenetics.

[36]  L. Servillo,et al.  SIRT1 and SIRT6 Signaling Pathways in Cardiovascular Disease Protection. , 2017, Antioxidants & redox signaling.

[37]  M. Vinciguerra,et al.  Induction of cancer cell stemness by depletion of macrohistone H2A1 in hepatocellular carcinoma , 2018, Hepatology.

[38]  M. Holeček.  Branched-chain amino acid supplementation in treatment of liver cirrhosis: Updated views on how to attenuate their harmful effects on cataplerosis and ammonia formation. , 2017, Nutrition.

[39]  Fude Fang,et al.  Cold-Inducible SIRT6 Regulates Thermogenesis of Brown and Beige Fat. , 2017, Cell reports.

[40]  Byung-Hyun Park,et al.  Hepatocyte‐specific sirtuin 6 deletion predisposes to nonalcoholic steatohepatitis by up‐regulation of Bach1, an Nrf2 repressor , 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[41]  J. Eriksson,et al.  SIRT6 polymorphism rs117385980 is associated with longevity and healthy aging in Finnish men , 2017, BMC Medical Genetics.

[42]  Guoheng Xu,et al.  Fat-Specific Sirt6 Ablation Sensitizes Mice to High-Fat Diet–Induced Obesity and Insulin Resistance by Inhibiting Lipolysis , 2017, Diabetes.

[43]  J. Leor,et al.  SIRT6 Overexpression Improves Various Aspects of Mouse Healthspan , 2016, The journals of gerontology. Series A, Biological sciences and medical sciences.

[44]  Yang Zhang,et al.  SIRT6 protects against palmitate-induced pancreatic β-cell dysfunction and apoptosis. , 2016, The Journal of endocrinology.

[45]  Jong Y. Park,et al.  Coexpression and expression quantitative trait loci analyses of the angiogenesis gene-gene interaction network in prostate cancer. , 2016, Translational cancer research.

[46]  Michael P Snyder,et al.  iPSC-derived cardiomyocytes reveal abnormal TGFβ signaling in left ventricular non-compaction cardiomyopathy , 2016, Nature Cell Biology.

[47]  I. Bergheim,et al.  Preventive effects of citrulline on Western diet-induced non-alcoholic fatty liver disease in rats. , 2016, The British journal of nutrition.

[48]  L. Henry,et al.  Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes , 2016, Hepatology.

[49]  Yonghao Yu,et al.  Chemical genetic discovery of PARP targets reveals a role for PARP-1 in transcription elongation , 2016, Science.

[50]  K. Ross,et al.  SIRT6 Suppresses Pancreatic Cancer through Control of Lin28b , 2016, Cell.

[51]  M. Vinciguerra,et al.  Biology, Epidemiology, Clinical Aspects of Hepatocellular Carcinoma and the Role of Sorafenib. , 2016, Current drug targets.

[52]  H. Reeves,et al.  Hepatocellular Carcinoma in Obesity, Type 2 Diabetes, and NAFLD , 2016, Digestive Diseases and Sciences.

[53]  M. Vinciguerra,et al.  MicroRNA-30 mediates anti-inflammatory effects of shear stress and KLF2 via repression of angiopoietin 2. , 2015, Journal of molecular and cellular cardiology.

[54]  Ibon Martínez-Arranz,et al.  Enhancing metabolomics research through data mining. , 2015, Journal of proteomics.

[55]  P. Taylor,et al.  Maternal obesity programs offspring non-alcoholic fatty liver disease through disruption of 24-h rhythms in mice , 2015, International Journal of Obesity.

[56]  José M. Mato,et al.  Data in support of enhancing metabolomics research through data mining , 2015, Data in brief.

[57]  Brian J. Smith,et al.  SIRT6 Minor Allele Genotype Is Associated with >5-Year Decrease in Lifespan in an Aged Cohort , 2014, PloS one.

[58]  G. Gores.  Decade in review—hepatocellular carcinoma: HCC—subtypes, stratification and sorafenib , 2014, Nature Reviews Gastroenterology &Hepatology.

[59]  N. Sundaresan,et al.  Regulation of Akt signaling by sirtuins: its implication in cardiac hypertrophy and aging. , 2014, Circulation research.

[60]  M. Vinciguerra,et al.  SIRT1-metabolite binding histone macroH2A1.1 protects hepatocytes against lipid accumulation , 2014, Aging.

[61]  P. Bork,et al.  Evolution and functional cross‐talk of protein post‐translational modifications , 2013, Molecular systems biology.

[62]  M. Vinciguerra,et al.  Liver diseases and aging: friends or foes? , 2013, Aging cell.

[63]  M. Vinciguerra.  Old age and steatohepatitis: A dangerous liaison? , 2013, Hepatology.

[64]  Lei Zhong,et al.  The sirtuin SIRT6 blocks IGF-Akt signaling and development of cardiac hypertrophy by targeting c-Jun , 2012, Nature Medicine.

[65]  J. Kirwan,et al.  Role of ceramides in nonalcoholic fatty liver disease , 2012, Trends in Endocrinology & Metabolism.

[66]  F. Villarroya,et al.  SIRT1 signaling as potential modulator of skeletal muscle diseases. , 2012, Current opinion in pharmacology.

[67]  Shelly C. Lu,et al.  Obesity-dependent metabolic signatures associated with nonalcoholic fatty liver disease progression. , 2012, Journal of proteome research.

[68]  Johan Auwerx,et al.  Sirtuins as regulators of metabolism and healthspan , 2012, Nature Reviews Molecular Cell Biology.

[69]  Ziv Bar-Joseph,et al.  The sirtuin SIRT6 regulates lifespan in male mice , 2012, Nature.

[70]  A. Seluanov,et al.  SIRT 6 Promotes DNA Repair Under Stress by Activating PARP 1 , 2012 .

[71]  A. Seluanov,et al.  SIRT6 overexpression induces massive apoptosis in cancer cells but not in normal cells , 2011, Cell cycle.

[72]  A. Seluanov,et al.  SIRT6 Promotes DNA Repair Under Stress by Activating PARP1 , 2011, Science.

[73]  Xiaoling Xu,et al.  Hepatic-specific disruption of SIRT6 in mice results in fatty liver formation due to enhanced glycolysis and triglyceride synthesis. , 2010, Cell metabolism.

[74]  Y. Kanfi,et al.  SIRT6 protects against pathological damage caused by diet‐induced obesity , 2010, Aging cell.

[75]  A. Bergman,et al.  Genetic variation in human telomerase is associated with telomere length in Ashkenazi centenarians , 2009, Proceedings of the National Academy of Sciences.

[76]  M. Vinciguerra,et al.  PTEN down-regulation by unsaturated fatty acids triggers hepatic steatosis via an NF-kappaBp65/mTOR-dependent mechanism. , 2008, Gastroenterology.

[77]  M. Vinciguerra,et al.  Microarray analyses and molecular profiling of steatosis induction in immortalized human hepatocytes , 2007, Laboratory Investigation.

[78]  I. Verma,et al.  Production and purification of lentiviral vectors , 2006, Nature Protocols.

[79]  A. Berzlanovich,et al.  Do centenarians die healthy? An autopsy study. , 2005, The journals of gerontology. Series A, Biological sciences and medical sciences.

[80]  G. Rennert,et al.  Clinical Phenotype of Families with Longevity , 2004, Journal of the American Geriatrics Society.